Open access · CC-BY
via OpenAlex
Metabolic engineering of Escherichia coli for biosynthesis of β‐nicotinamide mononucleotide from nicotinamide
Yang Liu, Montri Yasawong, Bo Yu
Microbial Biotechnology · 2021 · ▲ 57 citations
Abstract
Summary The β‐nicotinamide mononucleotide (NMN) is a key intermediate of an essential coenzyme for cellular redox reactions, NAD. Administration of NMN is reported to improve various symptoms, such as diabetes and age‐related physiological decline. Thus, NMN is attracting much attention as a promising nutraceutical. Here, we engineered an Escherichia coli strain to produce NMN from cheap substrate nicotinamide (NAM) and glucose. The supply of in vivo precursor phosphoribosyl pyrophosphate (PRPP) and ATP was enhanced by strengthening the metabolic flux from glucose. A nicotinamide phosphoribosyltransferase with high activity was newly screened, which is the key enzyme for converting NAM to NMN with PRPP as cofactor. Notably, the E. coli endogenous protein YgcS, which function is primarily in the uptake of sugars, was firstly proven to be beneficial for NMN production in this study. Fine‐tuning regulation of ygc S gene expression in the engineered E. coli strain increased NMN production. Combined with process optimization of whole‐cell biocatalysts reaction, a final NMN titre of 496.2 mg l ‐1 was obtained.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/1751-7915.13901
- Canonical
- link ↗
- Fetched
- 2026-11-04 MST
Cite this
APA
Liu, Y., Yasawong, M., & Yu, B. (2021). Metabolic engineering of Escherichia coli for biosynthesis of β‐nicotinamide mononucleotide from nicotinamide. <em>Microbial Biotechnology</em>. https://doi.org/10.1111/1751-7915.13901
Vancouver
Liu Y, Yasawong M, Yu B. Metabolic engineering of Escherichia coli for biosynthesis of β‐nicotinamide mononucleotide from nicotinamide. Microbial Biotechnology. 2021. doi:10.1111/1751-7915.13901.
BibTeX
@article{yang2021Metabo,
title = {Metabolic engineering of Escherichia coli for biosynthesis of β‐nicotinamide mononucleotide from nicotinamide},
author = {Yang Liu and Montri Yasawong and Bo Yu},
journal = {Microbial Biotechnology},
year = {2021},
doi = {10.1111/1751-7915.13901},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Microbial Physiology 2026
Open access · CC-BY
Semi-Rational Design of CpNampt Mutants for Enhanced Nicotinamide Mononucleotide (NMN) Synthesis in Saccharomyces cerevisiae
Catalysts 2023
Open access · CC-BY
Comprehensive Transformation of Escherichia coli for Nicotinamide Mononucleotide Production
Microbial Biotechnology 2024
Open access · CC-BY
De novo biosynthesis and nicotinamide biotransformation of nicotinamide mononucleotide by engineered yeast cells
Queensland University of Technology 2023
Preprint · CC-BY
Therapeutic potential of boosting NAD+ levels in aging and age-related bone loss
Foods 2026
Open access · CC-BY
Molecular Engineering of Nicotinamide Riboside Kinase and Process Optimization for Efficient Nicotinamide Mononucleotide Production
2025
Open access · CC-BY